🏭 GMP Manufacturing Facility
The GMP Manufacturing Facility enables Cancer Institute (WIA) to translate laboratory discoveries into clinical-grade cellular therapies. Designed to meet national and international regulatory standards, the facility supports the production of CAR-T cells, dendritic cell vaccines, and other advanced therapy medicinal products. Rigorous quality control and environmental monitoring ensure product safety and consistency throughout the manufacturing process.
Capabilities
Cleanroom suites classified to ISO 7 and ISO 5 standards for aseptic processing
Closed-system cell expansion and activation using automated bioreactors
Lentiviral and retroviral vector production for gene-modified cell therapies
In-process and release testing including sterility, endotoxin, and potency assays
Cryopreservation and controlled-rate freezing of cellular products
Quality management system aligned with CDSCO and WHO GMP guidelines
Access & Booking
Researchers interested in using this facility can request access by contacting the facility management team. Training sessions and orientation are available for new users.
Contact: facilities@cancerinstitutewia.org
Request Access